TP53 and neoplasm: Recent results suggest that p53 reactivation can promote innate and adaptive immunity through a variety of molecular pathways, and increase the immunogenicity of tumor cells, which provides a theoretical basis for targeted p53 drugs combined with immunotherapy.47